We studied here the independent roles of angiotensin II and aldosterone in regulating the sodium chloride cotransporter (NCC) of the distal convoluted tubule. We adrenalectomized three experimental and one control group of rats. Following surgery, the experimental groups were treated with either a high physiological dose of aldosterone, a non-pressor, or a pressor dose of angiotensin II for 8 days. Aldosterone and both doses of angiotensin II lowered sodium excretion and significantly increased the abundance of NCC in the plasma membrane compared with the control. Only the pressor dose of angiotensin II caused hypertension. Thiazides inhibited the sodium retention induced by the angiotensin II non-pressor dose. Both aldosterone and the non-pressor dose of angiotensin II significantly increased phosphorylation of NCC at threonine-53 and also increased the intracellular abundance of STE20/SPS1-related, proline alanine-rich kinase (SPAK). No differences were found in other modulators of NCC activity such as oxidative stress responsive protein type 1 or with-no-lysine kinase 4. Thus, our in vivo study shows that aldosterone and angiotensin II independently increase the abundance and phosphorylation of NCC in the setting of adrenalectomy; effects are likely mediated by SPAK. These results may explain, in part, the hormonal control of renal sodium excretion and the pathophysiology of several forms of hypertension. The conservation of sodium by the kidney is crucial for maintaining the extracellular fluid volume. The signal for the kidneys to conserve sodium is largely mediated by the renin-angiotensin-aldosterone system. Indeed, the majority of the renal sodium transporters were found to be regulated by this system, including the sodium hydrogen exchanger type 3 by angiotensin II, 1 and both the sodium chloride cotransporter (NCC) and the epithelial sodium channel (ENaC) by aldosterone. 2, 3 In recent years, a number of interacting kinase systems have been identified in the distal nephron, which directly or indirectly regulates renal sodium transport. The with-no-lysine kinases (WNK) positively or negatively regulate NCC and ENaC.
The conservation of sodium by the kidney is crucial for maintaining the extracellular fluid volume. The signal for the kidneys to conserve sodium is largely mediated by the renin-angiotensin-aldosterone system. Indeed, the majority of the renal sodium transporters were found to be regulated by this system, including the sodium hydrogen exchanger type 3 by angiotensin II, 1 and both the sodium chloride cotransporter (NCC) and the epithelial sodium channel (ENaC) by aldosterone. 2, 3 In recent years, a number of interacting kinase systems have been identified in the distal nephron, which directly or indirectly regulates renal sodium transport. The with-no-lysine kinases (WNK) positively or negatively regulate NCC and ENaC. [4] [5] [6] STE20/SPS1-related, proline alanine-rich kinase (SPAK) and oxidative stress responsive protein type 1 (OSR1) have been identified as proteins that are capable of phosphorylating NCC. 7, 8 Finally, serum-and glucocorticoid-inducible kinase 1 (SGK1) is pivotal in the regulation of ENaC, 9 and probably also NCC. 10, 11 These kinases were found to be sensitive to angiotensin II and aldosterone, which suggested them to have a central position in the receptor-transporter cascade. 4, 9, 12, 13 However, one crucial and unresolved question remains: what is the independent role of each of these hormones on sodium regulation in the distal nephron? 14, 15 We hypothesize that angiotensin II has effects independent of aldosterone on the renal sodium transporters and their regulatory kinases in the distal nephron. To test this, we conducted an experiment in which normal rats underwent adrenalectomy and then received either angiotensin II or aldosterone. Our results demonstrate specific effects of angiotensin II on the abundance and phosphorylation of NCC and its regulatory kinases.
RESULTS

Renin-angiotensin-aldosterone system
The experimental set-up is shown in Table 1 . Briefly, to analyze the independent effects of angiotensin II, all groups first underwent adrenalectomy and then received vehicle (control group), aldosterone (Aldo group, 50 mg/kg/day), or angiotensin II in a non-pressor (233 mg/kg/day) or a pressor (700 mg/kg/day) dose for 8 days. 16, 17 A fifth group of shamoperated rats was used only as a normal reference for plasma renin activity, and plasma angiotensin I, II, and aldosterone concentrations. As expected, plasma renin activity was reduced in the angiotensin II-treated groups compared with control ( Figure 1a ). Plasma renin activity was also reduced in the aldosterone-treated group, but only compared with the sham-operated animals. Plasma angiotensin I, but not plasma angiotensin II, followed the changes in plasma renin activity (Figure 1b and c). Plasma aldosterone showed high physiological levels in the aldosterone-treated group, normal levels in the sham-operated controls, and virtually undetectable levels in the other adrenalectomized groups (Figure 1d ).
Effects of aldosterone and angiotensin II on blood pressure, renal function, and sodium excretion
The administration of a pressor dose of angiotensin II resulted in a significant increase in mean arterial blood pressure compared with all other groups (Figure 2a ). No significant differences in blood pressure were observed in the other groups. The pressor dose of angiotensin II resulted in higher plasma creatinine concentrations compared with all other groups (Figure 2b ). In addition, the aldosterone-treated group also had higher plasma creatinine concentrations than the control group. Both aldosterone and angiotensin II reduced plasma potassium, but only aldosterone caused frank hypokalemia (3.2±0.06 mmol/l versus 4.3-5.2 mmol/l in the other groups, Po0.05 for all). Treatment with aldosterone and angiotensin II resulted in significantly lower 6-day cumulative sodium excretions compared with control (21 ± 3 mmol for Aldo, 31 ± 3 mmol for angiotensin II in a non-pressor, and 26 ± 7 mmol for angiotensin II in a pressor versus 39 ± 2 mmol for control; Figure 2c ). In addition, the animals treated with aldosterone had a lower cumulative sodium excretion than the animals treated with the nonpressor dose of angiotensin II. A separate study showed that the sodium retention caused by angiotensin II could be inhibited by hydrochlorothiazide (Figure 2d ).
Differential centrifugation and analysis by immunoblotting
The abundance of both transport proteins and regulatory proteins was analyzed by immunoblotting. As transport proteins are predominantly localized in plasma membrane, and regulatory proteins in the intracellular compartment, we used differential centrifugation to enrich both fractions (see Materials and Methods). A confirmation of this method is shown in Supplementary Figure S1 online, illustrating the enrichment of proteins localized in the plasma membrane (P-cadherin, sodium hydrogen exchanger type 3) or intracellular compartment (WNK4). Of all proteins tested and reported below, at least three immunoblots were performed. All results were consistent and showed similar statistics; the most representative immunoblots are shown. A Coomassie loading gel confirmed equal loading among the groups with a variation of o10% (Supplementary Figure S2 online).
Angiotensin II and aldosterone independently increased NCC, ENaC, and aquaporin-2
In these adrenalectomized rats, the non-pressor and pressor dose of angiotensin II increased the plasma membrane abundance of NCC 4.5-and 3.5-fold ( Figure 3) . Aldosterone increased the plasma membrane abundance of NCC threefold. The plasma membrane abundance of NCC did not differ between the three experimental groups. Interestingly, both aldosterone and angiotensin II increased the plasma membrane abundance of aquaporin-2 three-to fivefold compared with controls. This effect was stronger and dose-dependent in the angiotensin II-treated groups (higher abundance of aquaporin-2 with angiotensin II in a non-pressor versus Aldo and with angiotensin II in a pressor versus angiotensin II in a nonpressor). Only the non-pressor dose of angiotensin II selectively increased the plasma membrane abundance of the b-subunit of ENaC 1.8-fold. Conversely, only aldosterone treatment selectively increased the plasma membrane abundance of the a-subunit of ENaC approximately twofold. The infusion of angiotensin II or aldosterone did not result in significant differences in the plasma membrane abundance of the sodium hydrogen exchange type 3 and the sodium potassium chloride cotransporter type 2.
Angiotensin II increased SPAK independent of aldosterone
The non-pressor dose of angiotensin II significantly increased the intracellular abundance of SPAK twofold compared with the control group (Figure 4 ). This effect was not observed with the pressor dose of angiotensin II, which caused a lower intracellular abundance of SPAK than the non-pressor dose. Aldosterone treatment also increased the intracellular abundance of SPAK approximately threefold, which was significantly higher than the intracellular abundance of SPAK in all other groups. Aldosterone increased the phosphorylation of SPAK at serine-373 6.1-fold compared with control. The pressor dose of angiotensin II modestly reduced the intracellular abundance of SGK1 compared with the control group and with the group receiving aldosterone (both approximately 1.4-fold). The intracellular abundance of the other regulatory proteins that were tested, including OSR1, phosphorylated OSR1, WNK4, and NEDD4-2, did not change significantly.
Phosphorylation of NCC by angiotensin II and aldosterone
We analyzed whether angiotensin II also stimulated the phosphorylation of NCC. Indeed, the non-pressor dose of angiotensin II increased phosphorylation of NCC at threonine-53 in plasma membrane 4.3-fold ( Figure 5 ). Aldosterone also increased the phosphorylation of NCC at threonine-53 and to the same degree as the non-pressor dose of angiotensin II. Only aldosterone significantly increased phosphorylation of NCC at threonine-58 (1.7-fold). An antibody that recognized phosphorylation at both threonine-53 and threonine-58 also showed increased phosphorylation of NCC in the plasma membrane by aldosterone and by the non-pressor dose of angiotensin II.
Immunohistochemistry of phosphorylated NCC and aquaporin-2 Figure 6 shows immunohistochemistry for phosphorylated NCC at threonine-53 and for aquaporin-2. Immunohistochemistry showed increased labelling of phosphorylated NCC and aquaporin-2 in the three experimental groups, thereby confirming the immunoblotting results. In addition, Figure  6b shows that aquaporin-2 labelling was predominantly increased in the basolateral membrane.
DISCUSSION
In the present study, our aim was to test the hypothesis that angiotensin II regulates the NCC independently of aldosterone. Indeed, this is the first controlled in vivo study to show that angiotensin II under a chronic setting increased the abundance and phosphorylation of NCC independently of aldosterone, leading to sodium retention. The observation that sodium retention, secondary to angiotensin II, could be inhibited by thiazides ( Figure 2d ) suggests that at least part of this effect was mediated via NCC. However, it is not a direct proof of an NCC-mediated effect, because we did not test whether angiotensin II-treated animals were more sensitive to thiazides than control animals; it also remains to be determined whether the effect was direct. Because SPAK has been identified as a protein capable of phosphorylating the N-terminal regulatory regions of NCC, 12 the observed increase in SPAK ( Figure 4 ) suggests its involvement in the phosphorylation of NCC ( Figure 5 ). Although observational, our results provide further insight in the current model of the regulation of NCC ( Figure 7 ). Namely, our data confirm previous suggestions that two separate signaling pathways regulate NCC, one originating from the angiotensin II type 1 receptor and one originating from the mineralocorticoid receptor ( Figure 7 ). The net effect of both signaling pathways is a stimulation of sodium chloride reabsorption by NCC in the distal convoluted tubule. Although trafficking and phosphorylation of NCC by angiotensin II has been shown previously, 18, 19 this is the first study to demonstrate that these processes can occur independently of aldosterone.
Recently, in vitro studies have identified SPAK, WNK4, and SGK1 as important regulatory kinases in the signaling pathways stimulated by angiotensin II and aldosterone. 8, 11, 13 For example, San-Cristobal et al. 13 showed in oocytes of Xenopus and mpkDCT cells that the regulation of NCC by angiotensin II depends on both SPAK and WNK4. Furthermore, Rozansky et al. 11 showed in oocytes of Xenopus and HEK293 cells that aldosterone mediates the activation of NCC through SGK1-induced phosphorylation of the C-terminal WNK4. These findings prompted us to also analyze these NCC regulatory proteins.
We showed that both angiotensin II and aldosterone increased the intracellular abundance of SPAK, but not OSR1 (Figure 4) . The explanation for the fact that the intracellular abundance of SPAK was increased significantly more in the aldosterone-treated rats may be the consequence of the well-known synergistic interaction between (exogenous) aldosterone and (endogenous) angiotensin II in this group (Figure 1) . 20 The phosphorylation of SPAK also increased with angiotensin II and aldosterone, but this change was significant only for the latter. Recently, Chiga et al. 12 used low-and high-sodium diets in mice to analyze the effects of high and low aldosterone levels (plasma aldosterone B800 and B100 pg/ml) on SPAK, OSR1, and their phosphorylated forms. A high plasma aldosterone concentration increased the phosphorylation of SPAK and OSR1, but not their abundances. 12 Although our study confirms that aldosterone Cumulative sodium excretion was calculated based on 6-day urine volume and urine sodium (days 1 and 2 were discarded). Blood pressure was analyzed by a repeated measures general linear model. All other analyses were performed by analysis of variance followed by a post-hoc test (see Materials and Methods).
increases the phosphorylation of SPAK, we also observed an increase in the intracellular abundance of SPAK, but saw no effect on phosphorylated OSR1 (Figure 4 ). These differences may be related to the experimental models (diet versus infusion), species (mice versus rats), or tissue preparation (whole kidney homogenates versus intracellular fractions). 12 Despite our confirmation of the importance of SPAK, we observed no change in the intracellular abundance of WNK4 with angiotensin II or aldosterone (Figure 4 ). This is in agreement with two recent studies which also demonstrated the unchanged WNK4 abundance with low-sodium diet (high aldosterone) 12 and with chronic angiotensin II infusion. 21 However, these results do not preclude a role for WNK4, because it may be regulated through phosphorylation rather than through abundance, as shown by Rozansky et al. 11 Because we analyzed whole kidney homogenates, an alternative explanation is an opposite effect on WNK4 abundance in another nephron segment expressing WNK4 (e.g., thick ascending limb or collecting duct).
Similar to WNK4, we observed no change in SGK1 with aldosterone or the non-pressor dose of angiotensin II, and even observed a modest reduction in SGK1 with the pressor dose of angiotensin II (Figure 4) . Especially, the lack of response in SGK1 with aldosterone is surprising, because Vallon et al. 22 recently showed that increased abundance and phosphorylation of NCC with low-sodium diet (high aldosterone) did not occur in SGK1 knockout mice, illustrating the central role of SGK1 in NCC regulation. It has been proposed that angiotensin II also mediates its effect on the NCC via SGK1, 15 ,23 but this has not been confirmed Immunoblots showing the plasma membrane abundance of renal sodium and water transport proteins. These include the sodium hydrogen exchange type 3 (NHE3), the sodium potassium chloride cotransporter type 2 (NKCC2), the sodium chloride cotransporter (NCC), the water channel aquaporin-2 (AQP2), and finally the a-, b-, and g-subunits of the epithelial sodium channel (ENaC). Groups were compared by analysis of variance followed by a post-hoc test (see Materials and Methods).
experimentally. Although the pressor dose of angiotensin II reduced SGK1 (Figure 4) , we are reluctant to conclude that this was primarily because of angiotensin II, as these animals also had additional variables that could have caused this effect (i.e., hypertension and higher plasma creatinine; Figure 2 ). The same explanations for why WNK4 was unchanged in our model may also apply to SGK1. In addition, the effect of aldosterone on SGK1 may be dose dependent. For example, Hou et al. 24 demonstrated an eightfold rise in SGK1 mRNA in normal mice, but their plasma aldosterone concentrations were 410 times than in our aldosterone-treated rats. Using in situ hybridization, Chen et al. 9 also showed an increased abundance of SGK1 in adrenalectomized rats receiving aldosterone, but they also used 2 to 3 times higher dosing than we did. Finally, the plasma aldosterone concentrations of the mice on a low-sodium diet in the study by Vallon et al. 22 were almost twice as high as the ones in our aldosterone-treated rats.
A separate focus of this study was the effects of angiotensin II and aldosterone on the water channel aquaporin-2. Interestingly, both aldosterone and angiotensin II increased the plasma membrane abundance of aquaporin-2, showing the highest abundance with a pressor dose of angiotensin II (Figure 3) . The observed upregulation of aquaporin-2 by angiotensin II may represent a direct effect 25 or an indirect effect because of the ability of angiotensin II to increase vasopressin release. 26 Previously, the role of angiotensin II in aquaporin-2 regulation has been demonstrated in vivo in urinary tract obstruction. 27, 28 In mpkCCDc14 cells, long-term incubation with aldosterone o r i g i n a l a r t i c l e also increased aquaporin-2 protein abundance by increasing aquaporin-2 mRNA translation. 29 Our immunohistochemistry results ( Figure 6 ) confirm that of De Seigneux et al., 30 who also showed that aldosterone increased the basolateral staining of aquaporin-2 in the cortical collecting duct of rats. 30 They hypothesized that in situations of increased sodium reabsorption, a higher permeability of the basolateral membrane may facilitate water efflux to prevent cell swelling.
Except for aquaporin-2, the effects of the pressor dose of angiotensin II tended to be less pronounced than the effects of the non-pressor dose (Figure 3-5) . Possible explanations include the presence of hypertension (Figure 2a) , reduced renal function (Figure 2b) , or a downregulation of the angiotensin II type 1 receptor. As anticipated from previous studies, aldosterone also increased NCC, 3 in addition to a-ENaC 7 ( Figure 4) . Interestingly, the non-pressor dose of angiotensin II selectively increased b-ENaC. Previously, angiotensin II has been shown to increase the activity of ENaC. 31 However, the ENaC subunits appear differentially regulated by angiotensin II, because an angiotensin receptor blocker decreased a-ENaC, but increased b-ENaC. 32 Therefore, an alternative explanation could be that not angiotensin II but vasopressin increased b-ENaC, which was shown previously 33 and would also be consistent with the observed increase in aquaporin-2.
In this study, we focused on the regulation of NCC. Although NCC reabsorbs only 5-10% of the filtered load of sodium chloride, 19 altered function of this cotransporter has profound effects on total body sodium and blood pressure. This is illustrated by the fact that thiazides, which inhibit NCC, are among the most effective antihypertensive drugs. 34 Similarly, monogenetic disorders that result in inactivation (Gitelman's syndrome) or overactivation (Gordon's syndrome) of NCC are also characterized by salt-loss and low-normal blood pressure, or salt-retention and hypertension, respectively. 35 Finally, polymorphisms in genes encoding for NCC regulatory proteins, including WNK kinases and SPAK, are associated with variations in blood pressure in populations. Unravelling the independent effects of angiotensin II and aldosterone on NCC is important both physiologically and pathophysiologically. Physiologically, because angiotensin II and aldosterone had similar effects on sodium and water transporters (Figure 3) , both hormones appear to act in concert to maintain extracellular fluid volume during hypovolemia (when both hormones are elevated). Pathophysiologically, the renin-angiotensin-aldosterone system is activated in many disease states, and therefore, angiotensin II and aldosterone appear to individually contribute to sodium retention, which may result in edema and hypertension. These separate effects are important when selecting appropriate pharmacological intervention with angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or mineralocorticoid receptor blockers.
We believe that the strength of this study was the ability to analyze the effects of angiotensin II independent of aldosterone by performing adrenalectomy and then infusing angiotensin II. Adrenalectomy resulted in virtually undetectable aldosterone levels in the angiotensin II-treated groups (Figure 1) , thus confirming the validity of this approach. Other evidence supporting our animal model were aldosterone-induced hypokalemia and sodium retention, and angiotensin II-induced sodium retention and hypertension (Figure 2 ). Animals receiving aldosterone retained most of the sodium, but did not develop hypertension. This suggests that hypertension induced by the pressor dose of angiotensin II was mainly because of other mechanisms such as vasoconstriction, which may also explain the reduction in renal function (Figures 1 and 2) . A previous study also showed reduced renal function with a pressor dose of angiotensin II, which was attributed to renal cortical vasoconstriction. 38 The consequent decreased distal sodium delivery may explain why more angiotensin II infusion did not result in more sodium retention.
We acknowledge that our study has limitations. Most importantly, because whole kidney homogenates were used, some of the observed changes in protein abundance may not be specific for one nephron segment. In addition, the fact that plasma angiotensin II levels were not higher in animals receiving angiotensin II (Figure 1c) implies that plasma angiotensin II levels do not always correspond with their biological effect. We speculate that this may be explained by differences between endogenous and exogenous angiotensin II, accumulation of angiotensin II in renal tissue, or differences in angiotensin II degrading enzymes. 39 Finally, we appreciate that phosphorylation is sometimes expressed as the ratio between the phosphorylated and total amount of protein. 12 We chose not to do this, because it remains unclear whether there is a linear relationship between phosphorylation and total protein abundance. In addition, the increase in regulatory kinases suggested that more phosphorylation took place.
In summary, in adrenalectomized rats, angiotensin II increased the total and phosphorylated NCC independently of aldosterone. Phosphorylation of NCC by angiotensin II and aldosterone appears to be mediated through SPAK. These results are important for understanding the molecular physiology of sodium transport in the distal nephron, which not only is essential for maintaining the extracellular fluid volume, but also contributes to the pathophysiology of several forms of hypertension. 37, 40, 41 
METHODS
Animal studies
The animal protocol was approved by the Animal Care Committee of the Erasmus Medical Center (EUR 127-08-02). Male Sprague--Dawley rats (n ¼ 20, 15 weeks old, average weight 300 grams) were obtained from Charles River laboratories (Sulzfeld, Germany). Animals were randomly assigned to one of the four groups (Table 1) . On day 0, all animals were anaesthetized under 3% isoflurane inhalation and underwent adrenalectomy via a bilateral lumbodorsal incision. Immediately after adrenalectomy (also day 0), all animals received an osmotic minipump (model 2 ml2 Alzet, Cupertino, CA, USA) for 8 days to administer the hormones shown in Table 1 . All minipumps also contained dexamethasone (12 mg/kg/day, for glucocorticoid replacement). 42 After surgery, animals were placed in metabolic cages (day-night cycle 12 h, temperature 23 1C) from day 0 until day 8. Normal rat chow and drinking fluid (0.9% NaCl) were supplied ad libitum. Normal saline was selected to compensate for natriuresis after adrenalectomy. Blood pressure was measured every morning in conscious rats using a computerized tail cuff system after a 7-day acclimatization period (Kent Scientific Corporation, Torrington, CN, USA). On day 8, the animals were killed. A fifth group of sham-operated rats was only used as a normal reference for plasma renin activity, and plasma angiotensin I, II, and aldosterone concentrations. In a separate animal study following the same protocol, we compared urinary sodium excretion in adrenalectomized rats which received an osmotic minipump with vehicle, a non-pressor dose of angiotensin II (233 mg/kg/day), or a non-pressor dose of angiotensin II plus hydrochlorothiazide (18.75 mg/kg/day). 43 Tissue preparation and plasma measurements Plasma renin activity, angiotensin I and II, and aldosterone were measured using sensitive radioimmunoassays, as described previously. 44, 45 Plasma angiotensin II was expressed as natural logarithm because of a nonlinear distribution. The detection limit for plasma aldosterone was 1 pg/ml. If the measured value was below the detection limit, a value of 1 pg/ml was used as dummy variable for statistics. Immediately after the collection of blood, kidneys were harvested and placed on ice. The right kidney was used for immunoblotting and was placed in an isolation buffer (10 mmol/l triethanolamine, 250 mmol/l sucrose, protease inhibitors (Complete Roche Biochemicals, Roche Diagnostics, Almere, The Netherlands)) and homogenized. The whole kidney homogenate was subjected to differential centrifugation to separate the plasma membrane from the intracellular fraction, as described previously. 46 The pellet (plasma membrane fraction) was resuspended in 1 ml isolation buffer. A total of 60 ml of both fractions were used for quantitative protein assay (Pierce, Thermo Scientific, Rockford, IL, USA) and the remaining samples were stored in 6 Â Laemli at À80 1C for immunoblotting.
Immunoblotting Immunoblotting was performed as described previously.
2 Samples of all 20 rats were immunoblotted simultaneously using two gels in one transfer apparatus including an internal standard. All immunoblots were performed at least three times to confirm linearity and reproducibility. Equal protein loading was confirmed with Coomassie (Supplementary Figure S2 online) . Antibodies against the transport proteins, sodium hydrogen exchanger type 3 (1:5000), sodium potassium chloride cotransporter type 2 (1:10,000), NCC (1:500), the a-, b-, and g-subunits of ENaC (1:100, 1:1000, 1:500), and aquaporin-2 (1:1000) were kindly provided by Dr MA Knepper. 47 Antibodies against phosphorylated NCC at threonine-53 and/or -58 were generated by one of the investigators (RAF, all 1:500). 48 Antibodies against all other proteins were obtained: SPAK (Cell Signaling Technology, Leiden, The Netherlands, 1:300), SGK1 (Millipore, Billerica, MA, USA, 1:2000), and NEDD4-2 (Abcam, Cambridge, UK, 1:4000). Similarly, WNK4 (1:500), OSR1 (1:1000), and an antibody that recognized phosphorylated SPAK at serine-373 and phosphorylated OSR1 at serine-325 (4 mg/ml with 40 ml of the non-phosphorylated peptide) were obtained from the Division of Signal Transduction Therapy, University of Dundee. 8 
Immunohistochemistry
The left kidney was used for immunohistochemistry. The midregion was sectioned into 2-to 3-mm transverse sections and immersionfixed for an additional 1 h, followed by 3 Â 10 min washes with 0.1 mol/l cacodylate buffer, pH 7.4. The tissue was dehydrated in graded ethanol, incubated overnight in xylene, and embedded in paraffin, and 2-mm sections were cut on a rotary microtome (Leica Microsystems, Herlev, Denmark). Immunolabeling was performed as described previously. 27, 48 Labeling was detected using a horseradish peroxidase-conjugated secondary antibody (Dako P448, goat anti-rabbit IgG, Glostrup, Denmark) and visualized with 0.05% 3,3 0 -diaminobenzidine tetrachloride (Kemen Tek, Copenhagen, Denmark). Light microscopy was carried out with a Leica DMRE (Leica Microsystems).
Statistics
All data are expressed as means and s.e. of the mean. Group comparisons were made by analysis of variance using the least significant difference as post-hoc test. Blood pressure data were analyzed using repeated measures general linear model, which generates one P-value for the overall difference over time between the groups. Po0.05 was considered statistically significant.
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